About Nanobiotechnology
Nanobiotechnology is a discipline in which tools from nanobiotechnology are developed and applied to study biological phenomena.
Technavio’s analysts forecast the Global Nanobiotechnology Market to grow at a CAGR of 8.51% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the global nanobiotechnology market. To calculate the market size, the report considers the revenue generated from the sales of nanobiotechnology products such as nanoparticles, bionanomaterials, and liposomes.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, global nanobiotechnology market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Ablynx
• CELGENE
• Merck KGaA
• NanoBiotech Pharma
• Thermo Fisher Scientific
Market driver
• Increasing focus on nanotechnology research
• For a full, detailed list, view our report
Market challenge
• Lack of trained professionals
• For a full, detailed list, view our report
Market trend
• High prevalence of chronic diseases
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 07: MARKET SEGMENTATION BY END-USER
• Segmentation by end-user
• Comparison by end-user
• Pharmaceutical and biotechnology industry– Market size and forecast 2017-2022
• Medical devices – Market size and forecast 2017-2022
• Others – Market size and forecast 2017-2022
• Market opportunity by end-user
PART 08: CUSTOMER LANDSCAPE
PART 09: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Americas – Market size and forecast 2017-2022
• EMEA – Market size and forecast 2017-2022
• APAC – Market size and forecast 2017-2022
• Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 12: MARKET TRENDS
• Increasing demand for nanobiotechnology in stem cell therapy
• High prevalence of chronic diseases
• Growing use of gold nanoparticles
PART 13: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 14: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Ablynx
• CELGENE
• Merck KGaA
• NanoBiotech Pharma
• Thermo Fisher Scientific
PART 15: APPENDIX
• List of abbreviations
Exhibit 01: Parent market
Exhibit 02: Global nanotechnology market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global nanobiotechnology market– Market size and forecast 2017-2022 ($ bn)
Exhibit 09: Global nanobiotechnology market– Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: Global nanobiotechnology market by end-user – Market share 2017-2022 (%)
Exhibit 19: Comparison by end-user
Exhibit 20: Pharmaceutical and biotechnology industry – Market size and forecast 2017-2022 ($ bn)
Exhibit 21: Pharmaceutical and biotechnology industry – Year-over-year growth 2018-2022 (%)
Exhibit 22: Medical devices– Market size and forecast 2017-2022 ($ bn)
Exhibit 23: Medical devices– Year-over-year growth 2018-2022 (%)
Exhibit 24: Others – Market size and forecast 2017-2022 ($ bn)
Exhibit 25: Others – Year-over-year growth 2018-2022 (%)
Exhibit 26: Market opportunity by end-user
Exhibit 27: Customer landscape
Exhibit 28: Global nanobiotechnology market – Market share by geography 2017-2022 (%)
Exhibit 29: Regional comparison
Exhibit 30: Americas – Market size and forecast 2017-2022 ($ bn)
Exhibit 31: Americas – Year over year growth 2018-2022 (%)
Exhibit 32: Top three countries in Americas
Exhibit 33: EMEA – Market size and forecast 2017-2022 ($ bn)
Exhibit 34: EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 35: Top three countries in EMEA
Exhibit 36: APAC – Market size and forecast 2017-2022 ($ bn)
Exhibit 37: APAC – Year-over-year growth 2018-2022 (%)
Exhibit 38: Top 3 countries in APAC
Exhibit 39: Market opportunity
Exhibit 40: Nanobiotechnology-based products under clinical trials
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Vendors covered
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: Ablynx overview
Exhibit 47: Ablynx – Business segments
Exhibit 48: Ablynx – Organizational developments
Exhibit 49: Ablynx – Geographic focus
Exhibit 50: Ablynx – Segment focus
Exhibit 51: Ablynx – Key offerings
Exhibit 52: CELGENE overview
Exhibit 53: CELGENE – Business segments
Exhibit 54: CELGENE – Organizational developments
Exhibit 55: CELGENE – Geographic focus
Exhibit 56: CELGENE – Segment focus
Exhibit 57: CELGENE – Key offerings
Exhibit 58: Merck KGaA overview
Exhibit 59: Merck KGaA – Business segments
Exhibit 60: Merck KGaA – Organizational developments
Exhibit 61: Merck KGaA – Geographic focus
Exhibit 62: Merck KGaA – Segment focus
Exhibit 63: Merck KGaA – Key offerings
Exhibit 64: NanoBiotech Pharma overview
Exhibit 65: NanoBiotech Pharma – Business segments
Exhibit 66: NanoBiotech Pharma – Organizational developments
Exhibit 67: NanoBiotech Pharma – Geographic focus
Exhibit 68: NanoBiotech pharma – Key offerings
Exhibit 69: Thermo Fisher Scientific overview
Exhibit 70: Thermo Fisher Scientific – Business segments
Exhibit 71: Thermo Fisher Scientific – Organizational developments
Exhibit 72: Thermo Fisher Scientific – Geographic focus
Exhibit 73: Thermo Fisher Scientific – Segment focus
Exhibit 74: Thermo Fisher Scientific – Key offerings
Ablynx, CELGENE, Merck KGaA, NanoBiotech Pharma, and Thermo Fisher Scientific.
